Trials & Filings

Pfizer Receives FDA Approval of QuilliChew ER

Extended-Release ADHD treatment is now chewable

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pfizer received approval from the FDA for QuilliChew ER chewable tablets. QuilliChew ER is available in multiple dosage strengths with scored tablet options to individualize dosage. QuilliChew ER is chewable and can be taken with or without food. QuilliChew ER significantly improved attention and behavior compared to placebo in a clinical trial. The efficacy of QuilliChew ER was evaluated in a double-blind, randomized, placebo-controlled, parallel group laboratory classroom study in 90 childr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters